These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9625318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T, Gerken G, Meyer Zum Büschenfelde KH, Mayet WJ.
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antinuclear antibodies specific for primary biliary cirrhosis.
    Worman HJ, Courvalin JC.
    Autoimmun Rev; 2003 Jun; 2(4):211-7. PubMed ID: 12848948
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease.
    McLean F.
    Br J Biomed Sci; 2013 Jun; 70(1):10-4. PubMed ID: 23617092
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
    Granito A, Yang WH, Muratori L, Lim MJ, Nakajima A, Ferri S, Pappas G, Quarneti C, Bianchi FB, Bloch DB, Muratori P.
    Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
    [Abstract] [Full Text] [Related]

  • 9. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.
    Muratori P, Muratori L, Cassani F, Terlizzi P, Lenzi M, Rodrigo L, Bianchi FB.
    Clin Exp Immunol; 2002 Jan; 127(1):172-5. PubMed ID: 11882049
    [Abstract] [Full Text] [Related]

  • 10. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
    Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H.
    J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
    Bauer A, Habior A, Kraszewska E.
    J Immunoassay Immunochem; 2013 Mar; 34(4):346-55. PubMed ID: 23859785
    [Abstract] [Full Text] [Related]

  • 13. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.
    Sfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA.
    World J Gastroenterol; 2010 Oct 21; 16(39):4938-43. PubMed ID: 20954280
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation.
    Dubel L, Farges O, Courvalin JC, Sebagh M, Johanet C.
    J Hepatol; 1998 Jan 21; 28(1):169-70. PubMed ID: 9537858
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
    Janka C, Selmi C, Gershwin ME, Will H, Sternsdorf T.
    Hepatology; 2005 Mar 21; 41(3):609-16. PubMed ID: 15726652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.